title: Drug and device approval highlights from 2001.
abstract: The U.S. Food and Drug Administration approved more than 100 drugs and devices in 2001. This article discusses several of the new approvals, including ophthalmic drugs, contraceptive therapies, mental health medications, and medical devices.
authors.affiliation: University of Phoenix, USA.
authors.forename: Deborah
authors.initials: D
authors.lastname: Kupecz
authors.forename: Candace
authors.initials: C
authors.lastname: Berardinelli
mesh_terms: D000577:Amides; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000069580:Bimatoprost; D003008:Cloprostenol / Q000031:analogs & derivatives / Q000627:therapeutic use*; D003267:Contraception / Q000592:standards*; D018795:Device Approval; D003920:Diabetes Mellitus / Q000188:drug therapy; D017277:Drug Approval; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D007429:Intraocular Pressure; D008055:Lipids / Q000627:therapeutic use*; D008268:Macular Degeneration / Q000188:drug therapy*; D009798:Ocular Hypertension / Q000188:drug therapy*; D010138:Pacemaker, Artificial / Q000592:standards; D011166:Porphyrins / Q000627:therapeutic use*; D000069557:Travoprost; D014481:United States; D014486:United States Food and Drug Administration; D000077362:Verteporfin
chemical_list: D000577:Amides; D000959:Antihypertensive Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D008055:Lipids; D011166:Porphyrins; D000077362:Verteporfin; D000069036:Insulin Glargine; D003008:Cloprostenol; D000069580:Bimatoprost; D000069557:Travoprost